Investors Have Been Waiting to Buy the Dip in This Hot Biopharma Stock [Yahoo! Finance]
Jazz Pharmaceuticals plc - Ordinary Shares (JAZZ)
Last jazz pharmaceuticals plc - ordinary shares earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
jazzpharma.com
Company Research
Source: Yahoo! Finance
JAZZ exhibits strong technical momentum. Shares are up nearly 50% over the past year. The stock maintains a 100% “Buy” technical opinion from Barchart. Wall Street sentiment is bullish with multiple “Strong Buy” ratings and price targets up to $275. Today's Featured Stock Valued at $11.64 billion, Jazz Pharmaceuticals (JAZZ) is a specialty biopharmaceutical company with a focus in the areas of neuroscience and oncology. It derives most of its revenues from its sleep disorder drugs Xywav and Xyrem. Both drugs are approved for treating cataplexy and excessive daytime sleepiness in narcolepsy patients. What I'm Watching I found today's Chart of the Day by using Barchart's powerful screening functions to sort for stocks with the highest technical buy signals; superior current momentum in both strength and direction; and a Trend Seeker “buy” signal. I then used Barchart's Flipcharts feature to review the charts for consistent price appreciation. JAZZ checks those boxes. More
Show less
Read more
Impact Snapshot
Event Time:
JAZZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAZZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAZZ alerts
High impacting Jazz Pharmaceuticals plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
JAZZ
News
- Why Is Jazz (JAZZ) Down 3.9% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Jazz Pharmaceuticals (JAZZ) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health Education [Yahoo! Finance]Yahoo! Finance
- American Nutrition Association Announces Initiative with Jazz Pharmaceuticals to Advance Evidence-Based Sodium Reduction and Cardiovascular Health EducationPR Newswire
- Top 2026 Long Idea Competition: The Winners [Seeking Alpha]Seeking Alpha
JAZZ
Earnings
- 2/24/26 - Beat
JAZZ
Sec Filings
- 3/27/26 - Form SCHEDULE
- 3/9/26 - Form 4
- 3/9/26 - Form 4
- JAZZ's page on the SEC website